J&J Says Cherokees' Risperdal Suit Should Stay Federal
Johnson & Johnson Inc. and subsidiary Janssen Pharmaceuticals Inc. are fighting to keep a dispute over the mislabeling of antipsychotic drug Risperdal in federal court, arguing in a motion Monday that...To view the full article, register now.
Already a subscriber? Click here to view full article